Advantage Alpha Capital Partners LP Guardant Health, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $419 Million
- Q3 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 14,937 shares of GH stock, worth $528,769. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,937Holding current value
$528,769% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
324Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$414 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$398 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$359 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$245 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$212 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.62B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...